E
Eric B. Durbin
Researcher at University of Kentucky
Publications - 64
Citations - 1054
Eric B. Durbin is an academic researcher from University of Kentucky. The author has contributed to research in topics: Population & Cancer. The author has an hindex of 12, co-authored 50 publications receiving 541 citations. Previous affiliations of Eric B. Durbin include Markey Cancer Center.
Papers
More filters
Journal ArticleDOI
Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium.
Petros Grivas,Ali Raza Khaki,Ali Raza Khaki,Trisha Wise-Draper,Benjamin French,C. Hennessy,Chih-Yuan Hsu,Yu Shyr,X. Li,Toni K. Choueiri,Corrie A. Painter,Solange Peters,Brian I. Rini,Michael A. Thompson,Sanjay Mishra,Donna R. Rivera,Jared D. Acoba,Maheen Z. Abidi,Ziad Bakouny,Babar Bashir,T. S. Bekaii-Saab,Stephanie Berg,Eric H. Bernicker,Mehmet Asim Bilen,P. Bindal,Rohit Bishnoi,Nathaniel Bouganim,Daniel W. Bowles,Angelo Cabal,Paolo Caimi,David D. Chism,J. Crowell,Catherine Curran,Aakash Desai,Barry Dixon,Deborah B. Doroshow,Eric B. Durbin,Arielle Elkrief,Dimitrios Farmakiotis,A. Fazio,Leslie A. Fecher,Daniel Blake Flora,Christopher R. Friese,Julie Fu,Shirish M. Gadgeel,Matthew D. Galsky,David Gill,Michael Glover,Sharad Goyal,Punita Grover,Shuchi Gulati,Shilpa Gupta,Susan Halabi,Thorvardur R. Halfdanarson,Balazs Halmos,D. J. Hausrath,Jessica Hawley,Emily Hsu,Minh-Phuong Huynh-Le,Clara Hwang,Chinmay Jani,A. Jayaraj,Douglas B. Johnson,Anup Kasi,Hina Khan,Vadim S. Koshkin,Nicole M. Kuderer,Daniel Kwon,Philip E. Lammers,Ang Li,Arturo Loaiza-Bonilla,Clarke A. Low,Maryam B. Lustberg,Gary H. Lyman,Rana R. McKay,Christopher McNair,Harry Menon,Ruben A. Mesa,V. Mico,D. Mundt,Gayathri Nagaraj,E. S. Nakasone,John M. Nakayama,A. Nizam,N. L. Nock,Cathleen Park,Jaymin M. Patel,Kripa Patel,Prakash Peddi,Nathan A. Pennell,A. J. Piper-Vallillo,Matthew Puc,Deepak Ravindranathan,M. E. Reeves,D. Y. Reuben,Lori J. Rosenstein,Rachel P. Rosovsky,Samuel M. Rubinstein,M. Salazar,Andrew Schmidt,Gary K. Schwartz,Mansi R. Shah,Sumit A. Shah,Chintan Shah,Justin Shaya,Sunny R K Singh,M. Smits,Keith Stockerl-Goldstein,Daniel G. Stover,M. Streckfuss,Suki Subbiah,L. Tachiki,E. Tadesse,Astha Thakkar,Matthew D Tucker,Amit Verma,Donald C. Vinh,Matthias Weiss,Jia Wu,E. Wulff-Burchfield,Zhuoer Xie,Peter Paul Yu,Tian Zhang,Alice Zhou,Huili Zhu,Leyre Zubiri,Dimpy P. Shah,Jeremy L. Warner,Gd L. Lopes +128 more
TL;DR: In this article, the authors analyzed a cohort of patients with cancer and coronavirus 2019 (COVID-19) reported to the COVID19 and Cancer Consortium (CCC19) to identify prognostic clinical factors, including laboratory measurements and anticancer therapies.
Journal ArticleDOI
Incidence of brain metastasis at initial presentation of lung cancer
J. Lee Villano,Eric B. Durbin,Chris Normandeau,Jigisha P. Thakkar,Valentina Moirangthem,Faith G. Davis +5 more
TL;DR: The authors' analysis from the Kentucky and Alberta cancer registries similarly demonstrated the aggressive nature of lung cancer and its propensity for BM at initial presentation, and no synchronous organ site predicted BM in lung cancer.
Journal ArticleDOI
Effect of α1-Adrenoceptor Antagonist Exposure on Prostate Cancer Incidence: An Observational Cohort Study
Andrew M. Harris,Bradley W. Warner,John M. Wilson,Aaron Becker,Randall G. Rowland,William Conner,William Conner,Matthew Lane,Kimberly D. Kimbler,Kimberly D. Kimbler,Eric B. Durbin,Andre T. Baron,Andre T. Baron,Natasha Kyprianou +13 more
TL;DR: An exploratory, observational cohort study assesses the effect of α1-blocker exposure on the incidence of prostate cancer through the induction of apoptosis and decrease in tissue vascularity.
Journal ArticleDOI
Limitations of Transformers on Clinical Text Classification
Shang Gao,Mohammed Alawad,M. Todd Young,John Gounley,Noah Schaefferkoetter,Hong-Jun Yoon,Xiao-Cheng Wu,Eric B. Durbin,Jennifer A. Doherty,Antoinette M. Stroup,Linda Coyle,Georgia D. Tourassi +11 more
TL;DR: In this article, the authors introduce four methods to scale BERT, which by default can only handle input sequences up to approximately 400 words long, to perform document classification on clinical texts several thousand words long.
Journal ArticleDOI
Predicting the likelihood of an isocitrate dehydrogenase 1 or 2 mutation in diagnoses of infiltrative glioma
Li Chen,Zoya Voronovich,Kenneth Clark,Isaac Hands,Jonathan P. Mannas,Meggen Walsh,Marina N. Nikiforova,Eric B. Durbin,Heidi L. Weiss,Craig Horbinski +9 more
TL;DR: A multivariable model, incorporating patient age, glioblastoma multiforme diagnosis, and prior history of grade II or III glioma, was developed to predict IDH1/2 mutation probability and can help triage diffuse gliomas that would benefit from mutation testing in both clinical and research settings.